Cell Marker Predictors in Barrett's Esophagus

Sponsor
The Guthrie Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03316053
Collaborator
(none)
25
1
60.5
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.

Condition or Disease Intervention/Treatment Phase
  • Other: Tissue sample for genetic testing

Detailed Description

Patients with a history of Barrett's esophagus who are scheduled for a routine endoscopy will have an additional biopsy taken for genetic testing.

Study Design

Study Type:
Observational
Anticipated Enrollment :
25 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Cell Marker Predictors in Barrett's Esophagus
Actual Study Start Date :
Nov 15, 2017
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Tissue Sample for genetic testing

Biopsy sample

Other: Tissue sample for genetic testing
Tissue sample to be obtained during routine endoscopy

Outcome Measures

Primary Outcome Measures

  1. Cell Markers [through study completion, an average of 1 year]

    Identify genes involved in Barrett's Esophagus

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • History of Barrett's esophagus; scheduled for routine upper endoscopy
Exclusion Criteria:
  • Under 18 years of age

  • Unable to consent on own behalf

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Guthrie Clinic Sayre Pennsylvania United States 18840

Sponsors and Collaborators

  • The Guthrie Clinic

Investigators

  • Principal Investigator: John Ford, MD, The Guthrie Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Guthrie Clinic
ClinicalTrials.gov Identifier:
NCT03316053
Other Study ID Numbers:
  • 1708-43
First Posted:
Oct 20, 2017
Last Update Posted:
Feb 3, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2021